NEUROMETRIX, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 11 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-05-01: Reporting owner KATZ NANCY E; Form 4; Security Stock Option (right to buy Common Stock); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-05-01: Reporting owner Goodman David; Form 4; Security Stock Option (right to buy Common Stock); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-05-01: Reporting owner SURGENOR TIMOTHY R; Form 4; Security Stock Option (right to buy Common Stock); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-05-01: Reporting owner Van Avermaete David; Form 4; Security Stock Option (right to buy Common Stock); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-05-01 | KATZ NANCY E Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 16,971 owned after | $1.39 exercise price | 2018-05-02 | |
| 2018-05-01 | Goodman David Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 16,971 owned after | $1.39 exercise price | 2018-05-02 | |
| 2018-05-01 | SURGENOR TIMOTHY R Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 16,971 owned after | $1.39 exercise price | 2018-05-02 | |
| 2018-05-01 | Van Avermaete David Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 17,252 owned after | $1.39 exercise price | 2018-05-02 | |
| 2018-01-25 | Goodman David Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 11,971 owned after | $1.78 | 2018-01-29 | |
| 2018-01-25 | SURGENOR TIMOTHY R Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 11,971 owned after | $1.78 | 2018-01-29 | |
| 2018-01-25 | KATZ NANCY E Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 11,971 owned after | $1.78 | 2018-01-29 | |
| 2018-01-25 | Van Avermaete David Director | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 12,252 owned after | $1.78 | 2018-01-29 | |
| 2018-01-25 | Gozani Shai Director, Officer (President & CEO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 100,000 owned after | $1.78 | 2018-01-26 | |
| 2018-01-25 | MCGILLIN FRANCIS X Officer (SVP, Chief Commercial Officer) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 50,000 owned after | $1.78 | 2018-01-26 | |
| 2018-01-25 | HIGGINS THOMAS T Officer (Senior Vice President, CFO) | 4 | Stock Option (right to buy Common Stock) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 50,000 owned after | $1.78 | 2018-01-26 |